Arcoma AB (STO:ARCOMA)
Sweden
· Delayed Price · Currency is SEK 8.00
-0.62 (-7.19%)
Mar 9, 2026, 5:17 PM CET
Arcoma AB Revenue
In the year 2025, Arcoma AB had annual revenue of 130.80M SEK, down -16.59%. Arcoma AB had revenue of 34.66M in the quarter ending December 31, 2025, a decrease of -5.82%.
Revenue
130.80M
Revenue Growth
-16.59%
P/S Ratio
0.94
Revenue / Employee
4.22M
Employees
31
Market Cap
123.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.80M | -26.01M | -16.59% |
| Dec 31, 2024 | 156.81M | -6.21M | -3.81% |
| Dec 31, 2023 | 163.02M | 37.97M | 30.36% |
| Dec 31, 2022 | 125.05M | 7.92M | 6.76% |
| Dec 31, 2021 | 117.13M | -287.00K | -0.24% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scandinavian Real Heart AB (Publ) | 153.10K |
| Iconovo AB | 14.53M |
| SciBase Holding AB | 36.59M |
| Episurf Medical AB | 20.20M |
| Nosa Plugs AB | 24.12M |
| Boule Diagnostics AB | 489.70M |
| Clinical Laserthermia Systems AB | 17.49M |
| Integrum AB | 98.18M |